The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis
Pituitary. 2025 Oct 5;28(5):106. doi: 10.1007/s11102-025-01581-6. ABSTRACT PURPOSE: Craniopharyngiomas (CPs) cause hypopituitarism in most patients, with growth hormone deficiency (GHD) being the most prevalent form. …